2m 2m 2m 2m 2m 2m 2m
ADMA Biologics (ADMA)
NASDAQ
$9.28+$0.05 (+0.50%)
Price as of Sep 11, 2026 7:30 PM EDT- $2.1BMarket Cap
- -42.71%1-Year Change
- BiotechnologyIndustry
ADMA Biologics (ADMA)
$9.28+$0.05 (+0.50%)
ADMA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.23 | ||
Change | -$0.16 (-1.70%) | ||
Open | $9.44 | ||
High | $9.50 | ||
Low | $9.20 | ||
Previous Close | $9.39 | ||
Volume | 2,266,782 | ||
30-Day Average Volume | 1,882,554 | ||
1-Week Change | -4.05% | ||
1-Month Change | -6.81% | ||
1-Year Change | -42.71% | ||
3-Year Change | 141.62% | ||
5-Year Change | 675.63% | ||
Fundamentals | |||
Shares Outstanding | 224.0M | ||
Total Assets | $684.2M | ||
Market Cap | $2.1B | ||
Enterprise Value | $2.1B | ||
Period: QTR TTM FY | |||
Revenue | $124.4M | ||
Net Income | $37.8M | ||
Free Cash Flow | $27.3M | ||
EBIT | $50.2M | ||
EBITDA | $52.0M | ||
Net Working Capital | $452.4M | ||
EPS | $0.16 | ||
Enterprise Value/EBITDA | 41 | ||
Enterprise Value/Revenue | 17 | ||
P/B | 5 | ||
P/E | 58 | ||
PEG | -4 | ||
Price/Free Cash Flow | 76 | ||
Price/Operating Cash Flow | 70 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue